Beijing, China · Founded 2016 · Privately Held (backing)
Operator of an innovative pharmaceutical company intended to be specialized in innovative drug research, clinically valuable generic drug development and pharmaceutical industrialization. PrimeGene (Beijing) is based in Beijing, China and was founded in 2016. Its last reported valuation was $248 million in Jan 2025. It has raised $85.6 million.
Last reported valuation
$248.0M
Oct 2026
Priced at
—
Total raised
$85.6M
Last round
—
Team — not yet on record
No current team members for PrimeGene (Beijing) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PrimeGene (Beijing) with a free account
·Watch PrimeGene (Beijing): the Monday email on marks, rounds and moves
